MarketingRx roundup: Bluebird bio promotes sickle cell awareness; Pfizer, BioNTech encourage boosters in South
While bluebird bio is expected to file an application with the FDA for its sickle cell disease (SCD) drug candidate in the first quarter, it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
